(97 days)
Not Found
No
The description focuses on standard signal processing and calculation based on light absorption measurements, with no mention of AI/ML algorithms for data analysis or interpretation.
No
The device is a monitor that tracks trends in regional hemoglobin oxygen saturation; it does not provide treatment.
Yes
The device is intended as an "adjunct monitor of trends in regional hemoglobin oxygen saturation" and provides "real-time cerebral oximetry trend data," which are functions used to provide information about a patient's physiological state. While it is an "adjunct monitor," it still provides data for assessment, making it a diagnostic device.
No
The device description explicitly states it is comprised of three hardware subsystems: sensor, patient oximetry device (Pod), and display unit.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Nonin Model 7600 Regional Oximeter System is a non-invasive device that measures regional hemoglobin oxygen saturation underneath the sensor placed on the patient's forehead. It does not analyze samples taken from the body.
- Method of Measurement: It uses near-infrared spectroscopy to measure light absorption through the tissue, not to analyze the composition of a biological sample.
Therefore, while it is a medical device used for diagnosis and monitoring, it falls under the category of in vivo (within the living body) diagnostic or monitoring devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
Nonin's stand-alone non-invasive Model 7600 Regional Oximeter System is intended for use as an adjunct monitor of trends in regional hemoglobin oxygen saturation of blood underneath the sensor. It is intended for spot-checking or continuous monitoring of adult or pediatric patients weighing greater than 88 pounds (40 kilograms). It is intended for use in environments including the operating room, surgical recovery, critical care, emergency room, long-term care and mobile environments.
Product codes
DQA, MUD
Device Description
Nonin's® Model 7600 non-invasive Regional Oximeter System continuously monitors and records the mixed arterial/venous blood oxygen levels through non-invasive near-infrared spectroscopy sensors placed on the patient's forehead.
The stand-alone system is comprised of three subsystems; sensor, patient oximetry device (Pod) and display unit. The sensor allows light absorption measurements at various wavelengths in the near infrared spectrum (approximately 700 to 900 nanometers). The sensor is approximately 1.5 by 3 inches.
The sensors plug into the patient oximetry device (Pod) which controls the light emitted from the sensor LEDs and measures the light returning to the sensor photodiodes. From these measurements, the Pod determines specific absorption values and calculates the mixed arterial/venous oxygen saturation values. The Pods then communicate the cerebral oxygen saturation readings and other data to the display unit.
The display unit displays real-time cerebral oximetry trend data. It is a battery-backed, mains powered device equipped with audio and visual alarm indicators. Real-time data and playback output is accomplished through a Bluetooth transceiver module.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
underneath the sensor (placed on the patient's forehead)
Indicated Patient Age Range
adult or pediatric patients weighing greater than 88 pounds (40 kilograms).
Intended User / Care Setting
operating room, surgical recovery, critical care, emergency room, long-term care and mobile environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonin's Model 7600 Regional Oximeter System has successfully undergone both laboratory and clinical testing in order to ensure that it has appropriate functional features and is substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
:
section 2. Summary and certification
1 ..
,
| 510(k) Summary | JUN 30 2009 |
|---|---|
| Submitter: | Nonin Medical, Inc. |
| Contact Person: | Lori M. Roth |
| Clinical/Regulatory Specialist | |
| Nonin Medical, Inc. | |
| 13700 1st Ave. North | |
| Plymouth, MN 55441-5443 | |
| Date Prepared: | March 24, 2009 |
| Trade Name: | Model 7600 Regional Oximeter System |
| Classification Name: | |
| and Number: | Class II, 21 CFR 870.2700 |
| Product Code: | DQA |
| Predicate Device(s): | Nonin's Model 7600 Regional Oximeter System is substantially |
| equivalent to the INVOS® Model 5100 Cerebral Oximeter | |
| manufactured by Somanetics Corporation that was cleared by the | |
| FDA under K001842 on 9/15/00. | |
| Device Description: | Nonin's® Model 7600 non-invasive Regional Oximeter System |
| continuously monitors and records the mixed arterial/venous | |
| blood oxygen levels through non-invasive near-infrared | |
| spectroscopy sensors placed on the patient's forehead. | |
| The stand-alone system is comprised of three subsystems; sensor, | |
| patient oximetry device (Pod) and display unit. The sensor allows | |
| light absorption measurements at various wavelengths in the near | |
| infrared spectrum (approximately 700 to 900 nanometers). The | |
| sensor is approximately 1.5 by 3 inches. | |
| The sensors plug into the patient oximetry device (Pod) which | |
| controls the light emitted from the sensor LEDs and measures the | |
| light returning to the sensor photodiodes. From these | |
| measurements, the Pod determines specific absorption values | |
| and calculates the mixed arterial/venous oxygen saturation | |
| values. The Pods then communicate the cerebral oxygen |
1
saturation readings and other data to the display unit.
The display unit displays real-time cerebral oximetry trend data. It is a battery-backed, mains powered device equipped with audio and visual alarm indicators. Real-time data and playback output is accomplished through a Bluetooth transceiver module.
Nonin's stand-alone non-invasive Model 7600 Regional Oximeter
System is intended for use as an adjunct monitor of trends in regional hemoglobin oxygen saturation of blood underneath the sensor. It is intended for spot-checking or continuous monitoring of adult or pediatric patients weighing greater than 88 pounds (40 kilograms). It is intended for use in environments including the operating room, surgical recovery, critical care, emergency room,
Intended Use:
Functional and Safety Testing:
Conclusion:
long-term care and mobile environments. Nonin's Model 7600 Regional Oximeter System has successfully undergone both laboratory and clinical testing in order to ensure that it has appropriate functional features and is substantially
Nonin's Model 7600 Regional Oximeter System is substantially equivalent to the INVOS® Model 5100 Cerebral Oximeter manufactured by Somanetics Corporation and cleared by the FDA under K001842 on 9/15/00.
equivalent to the predicate device.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three stripes on its wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circle around the eagle.
Public Health Service
JUN 3 0 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Nonin Medical, Inc. c/o Lori Roth RN, BSN Clinical/Regulatory Specialist 13700 154 Avenue North Plymouth, MN 55441-5443
Re: K090807
Trade/Device Name: Model 7600 Regional Oximeter System Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: MUD Dated: June 2, 2009 Received: June 3, 2009
Dear Ms. Roth:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Kesia Alexander for
Malvina B. Eydelman, M.B Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Statement
510(k) Number: K090807
Device Name:
Nonin Medical, Inc. Model 7600 Regional Oximeter System
Indications for Use:
Nonin's stand-alone non-invasive Model 7600 Regional Oximeter System is intended for use as an adjunct monitor of trends in regional hemoglobin oxygen saturation of blood underneath the sensor. It is intended for spot-checking or continuous monitoring of adult or pediatric patients weighing greater than 88 pounds (40 kilograms). It is intended for use in environments including the operating room, surgical recovery, critical care, emergency room, long-term care and mobile environments.
Prescription Use × (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
AND/OR
Concurrence of CDRH, Office of Device Evaluation (ODE)
M.R. Bicholas
(Division Sign-Off Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number K090801